Role of STRAP in regulating GSK3β function and Notch3 stabilization

Cell Cycle

Volumn 10, Issue 10, 2011, Pages 1639-1654

  Kashikar, Nilesh D ^a   Zhang, Wanguang ^a   Massion, Pierre P ^a   Gonzalez, Adriana L ^a   Datta, Pran K ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axin; GSK3 ; Lung cancer; Notch3; STRAP; Ubiquitination

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; AR A01441; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; NOTCH3 RECEPTOR; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; WESTERN BLOTTING;

EID: 79955983829     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.10.15630     Document Type: Article

References (63)

1. Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 2000; 9:2431-8.
2. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-9. (Pubitemid 26004411)
3. Xu C, Kim NG, Gumbiner BM. Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 2009; 8:4032-9.
4. Lai EC. Notch signaling: control of cell communication and cell fate. Development 2004; 131:965-73. (Pubitemid 38380451)
5. Lewis J. Notch signalling and the control of cell fate choices in vertebrates. Semin Cell Dev Biol 1998; 9:583-9. (Pubitemid 128647238)
6. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev 1992; 6:2620-34. (Pubitemid 23052889)
7. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC. gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 2000; 287:1820-4.
8. Weng AP, Ferrando AA, Lee W, Morris JP, 4th, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306:269-71. (Pubitemid 39336870)
9. Bismar TA, Demichelis F, Riva A, Kim R, Varambally S, He L, et al. Defining aggressive prostate cancer using a 12-gene model. Neoplasia 2006; 8:59-68.
10. Indraccolo S, Minuzzo S, Masiero M, Amadori A. Ligand-driven activation of the notch pathway in T-ALL and solid tumors: why Not(ch)? Cell Cycle 2010; 9:80-5.
11. De La O JP, Murtaugh L. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling. Cell Cycle 2009; 8:1860-4.
12. Dang TP, Eichenberger S, Gonzalez A, Olson S, Carbone DP. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene 2003; 22:1988-99.
13. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, et al. Notch signalling controls pancreatic cell differentiation. Nature 1999; 400:877-81. (Pubitemid 29406724)
14. Haruki N, Kawaguchi KS, Eichenberger S, Massion PP, Olson S, Gonzalez A, et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005; 65:3555-61. (Pubitemid 40616330)
15. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 2001; 108:161-4. (Pubitemid 32918185)
16. Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007; 67:8051-7. (Pubitemid 47395139)
17. Talora C, Campese AF, Bellavia D, Pascucci M, Checquolo S, Groppioni M, et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003; 4:1067-72.
18. Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003; 3:565-76. (Pubitemid 36808651)
19. Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD, et al. Chromosome 19 translocation, overexpression of Notch3 and human lung cancer. J Natl Cancer Inst 2000; 92:1355-7. (Pubitemid 30660597)
20. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004; 10:3291-300. (Pubitemid 38685433)
21. Yamaguchi N, Oyama T, Ito E, Satoh H, Azuma S, Hayashi M, et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008; 68:1881-8. (Pubitemid 351416574)
22. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007; 3.
23. Hong M, Chen DC, Klein PS, Lee VM. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997; 272:25326-32. (Pubitemid 27415724)
24. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1997; 93:8455-9.
25. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr Biol 1996; 6:1664-8. (Pubitemid 27050234)
26. Chalecka-Franaszek E, Chuang DM. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 1999; 96:8745-50. (Pubitemid 29354862)
27. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 2000; 7:793-803.
28. Hongisto V, Vainio JC, Thompson R, Courtney MJ, Coffey ET. The Wnt pool of glycogen synthase kinase-3beta is critical for trophic-deprivation-induced neuronal death. Mol Cell Biol 2008; 28:1515-27.
29. Rinnab L, Schütz SV, Diesch J, Schmid E, Küfer R, Hautmann RE, et al. Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful? Neoplasia 2008; 10:624-34.
30. Tighe A, Ray-Sinha A, Staples OD, Taylor SS. GSK-3 inhibitors induce chromosome instability. BMC Cell Biol 2007; 8.
31. Yu JY, Taylor J, DeRuiter SL, Vojtek AB, Turner DL. Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther 2003; 7:228-36. (Pubitemid 36395358)
32. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 2000; 7:793-803.
33. Guo X, Ramirez A, Waddell DS, Li Z, Liu X, Wang XF. Axin and GSK3-control Smad3 protein stability and modulate TGF-signaling. Genes Dev 2008; 22:106-20.
34. Espinosa L, Inglés-Esteve J, Aguilera C, Bigas A. Phosphorylation by glycogen synthase kinase-3beta downregulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 2003; 278:32227-35. (Pubitemid 37048415)
35. Foltz DR, Santiago MC, Berechid BE, Nye JS. Glycogen synthase kinase-3β modulates notch signaling and stability. Curr Biol 2002; 12:1006-11. (Pubitemid 34703331)
36. Jin YH, Kim H, Oh M, Ki H, Kim K. Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta. Mol Cells 2009; 27:15-9.
37. Zheng H, Saito H, Masuda S, Yang X, d Takano Y. Phosphorylated GSK3β-ser9 and EGFR are Good Prognostic Factors for Lung Carcinomas. Anticancer Res 2007; 27:3561-9.
38. Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 2004; 13:1435-48. (Pubitemid 38669232)
39. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3beta. Curr Biol 1998; 8:573-81.
40. Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc Natl Acad Sci USA 1998; 95:9637-41. (Pubitemid 28506284)
41. Datta PK, Chytil A, Gorska AE, Moses HL. Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 1998; 273:34671-4. (Pubitemid 29028152)
42. Tretyakova I, Zolotukhin AS, Tan W, Bear J, Propst F, Ruthel G, et al. Nuclear export factor family protein participates in cytoplasmic mRNA trafficking. J Biol Chem 2005; 280:31981-90. (Pubitemid 41291949)
43. Xu C, Kim G, Gumbiner M. Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 2009; 8:4032-9.
44. Takahashi K, Adachi K, Yoshizaki K, Kunimoto S, Kalaria RN, Watanabe A. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet 2010; 19:79-89.
45. Zhang W, Yang J, Liu Y, Chen X, Yu T, Jia J, Liu C. PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation. J Biol Chem 2009; 284:22649-56.
46. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase-3 phosphorylation- dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101:9085-90. (Pubitemid 38781615)
47. Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007; 9:765-74. (Pubitemid 47019463)
48. Qiu L, Joazeiro C, Fang N, Wang HY, Elly C, Altman Y, et al. Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J Biol Chem 2000; 275:35734-7.
49. Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Iida K, et al. Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecol Oncol 2010; 117:409-16.
50. Doucas H, Mann CD, Sutton CD, Garcea G, Neal CP, Berry DP, et al. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol 2008; 97:63-8.
51. Chen ZJ, Sun LJ. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 2009; 13:275-86.
52. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005; 123:409-21. (Pubitemid 41546672)
53. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP. Regulation of transcriptional activation domain function by ubiquitin. Science 2001; 293:1651-3. (Pubitemid 32807843)
54. Archer CT, Delahodde A, Gonzalez F, Johnston SA, Kodadek T. Activation domain-dependent monoubiquitylation of Gal4 protein is essential for promoter binding in vivo. J Biol Chem 2008; 283:12614-23.
55. Hurley JH, Lee S, Prag G. Ubiquitin-binding domains. Biochem J 2006; 399:361-72. (Pubitemid 44672627)
56. Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 2004; 18:2730-5. (Pubitemid 39507766)
57. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 2004; 18:2469-73. (Pubitemid 39362888)
58. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444:1083-7. (Pubitemid 46018529)
59. Hellström M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445:776-80. (Pubitemid 46279716)
60. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 2004; 18:2474.
61. Weinmaster G, Kintner C. Modulation of notch signaling during somitogenesis. Annu Rev Cell Dev Biol 2003; 19:367-95. (Pubitemid 37487353)
62. Ikeya T, Hayashi S. Interplay of Notch and FGF signaling restricts cell fate and MAPK activation in the Drosophila trachea. Development 1999; 126:4455-63.
63. Khokhar A, Chen N, Yuan JP, Li Y, Landis GN, Beaulieu G, et al. Conditional switches for extracellular matrix patterning in Drosophila melanogaster. Genetics 2008; 178:1283-93.